0001613386-18-000001.txt : 20180601 0001613386-18-000001.hdr.sgml : 20180601 20180531181853 ACCESSION NUMBER: 0001613386-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180601 DATE AS OF CHANGE: 20180531 EFFECTIVENESS DATE: 20180601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aminex Therapeutics, Inc. CENTRAL INDEX KEY: 0001613386 IRS NUMBER: 263969765 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313679 FILM NUMBER: 18872935 BUSINESS ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 BUSINESS PHONE: 425-286-4222 MAIL ADDRESS: STREET 1: 11335 NE 122ND STREET 2: SUITE 105 CITY: KIRKLAND STATE: WA ZIP: 98034 D 1 primary_doc.xml X0708 D LIVE 0001613386 Aminex Therapeutics, Inc. 11335 NE 122ND SUITE 105 KIRKLAND WA WASHINGTON 98034 425-286-4222 WASHINGTON None None Corporation true Thomas Graham 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director James Skaggs 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director Mark Burns 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Executive Officer Director Jeff Miller 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director Rhonda Rhyne 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director Stacy Hock 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director Roger Ulrich 11335 NE 122nd Suite 105 Kirkland WA WASHINGTON 98034 Director Biotechnology Decline to Disclose 06b false 2018-05-17 false true false 0 14166867 8253117 5913750 false 96 0 0 0 false Aminex Therapeutics, Inc. /s/ Thomas Graham Thomas Graham Chief Operating Officer 2018-05-31